NEW YORK (GenomeWeb News) – Gen-Probe has submitted an application with the US Food and Drug Administration for regulatory approval of a genotyping assay for human papillomavirus.

A spokesman for the San Diego-based company today confirmed the PMA submission. The assay will run on the Tigris system and will detect for type 16 alone and type 18/45 together. The spokesman declined to comment about when a decision from FDA is expected.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.